吉西他滨2h固定速率静滴联合顺铂治疗晚期非小细胞肺癌的临床观察(3)
[7]Schmid P, Akrivakis K, Flath B, et al. Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancer[J]. Anticancer Drugs, 1999, 10(7): 625-631.
[8]Rizzieri DA, Bass AJ, Rosner GL, et al. Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia[J]. J Clin Oncol,2002,20(3):674-679.
[9]Grunewald R, Kantarjian H, Keating MJ, et al. Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia[J].Cancer Res, 1990, 50(21):6823-6826.
[10]钱俐,茅国新,李梅,等.吉西他滨联合铂类化疗药物治疗晚期非小细胞肺癌临床观察[J].肿瘤基础与临床, 2006, 19(6): 480-482.
[11] 刘海龙,雷恒,张华,等.吉西他滨联合顺铂与长春瑞滨联合顺铂治疗晚期非小细胞肺癌的临床疗效观察[J]. 临床和实验医学杂志,2007,6(7):58-59.
[12] Soo RA, Wang LZ, Tham LS, et al. A muticentre randomized phase Ⅱstudy of carboplatin in combination with Gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small cell lung cancer[J].Annals of Oncology,2006,17(7):1128-1133.
(收稿日期：2008-10-29), 百拇医药(张晓东 顾红兵 陆俊国 谭清和)
[8]Rizzieri DA, Bass AJ, Rosner GL, et al. Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia[J]. J Clin Oncol,2002,20(3):674-679.
[9]Grunewald R, Kantarjian H, Keating MJ, et al. Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia[J].Cancer Res, 1990, 50(21):6823-6826.
[10]钱俐,茅国新,李梅,等.吉西他滨联合铂类化疗药物治疗晚期非小细胞肺癌临床观察[J].肿瘤基础与临床, 2006, 19(6): 480-482.
[11] 刘海龙,雷恒,张华,等.吉西他滨联合顺铂与长春瑞滨联合顺铂治疗晚期非小细胞肺癌的临床疗效观察[J]. 临床和实验医学杂志,2007,6(7):58-59.
[12] Soo RA, Wang LZ, Tham LS, et al. A muticentre randomized phase Ⅱstudy of carboplatin in combination with Gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small cell lung cancer[J].Annals of Oncology,2006,17(7):1128-1133.
(收稿日期：2008-10-29), 百拇医药(张晓东 顾红兵 陆俊国 谭清和)